180 related articles for article (PubMed ID: 24089243)
1. Stable insulin-secreting ducts formed by reprogramming of cells in the liver using a three-gene cocktail and a PPAR agonist.
Banga A; Greder LV; Dutton JR; Slack JM
Gene Ther; 2014 Jan; 21(1):19-27. PubMed ID: 24089243
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA.
Akinci E; Banga A; Greder LV; Dutton JR; Slack JM
Biochem J; 2012 Mar; 442(3):539-50. PubMed ID: 22150363
[TBL] [Abstract][Full Text] [Related]
3. In vivo direct reprogramming of liver cells to insulin producing cells by virus-free overexpression of defined factors.
Yang XF; Ren LW; Yang L; Deng CY; Li FR
Endocr J; 2017 Mar; 64(3):291-302. PubMed ID: 28100871
[TBL] [Abstract][Full Text] [Related]
4. Stage specific reprogramming of mouse embryo liver cells to a beta cell-like phenotype.
Yang Y; Akinci E; Dutton JR; Banga A; Slack JM
Mech Dev; 2013; 130(11-12):602-12. PubMed ID: 23994012
[TBL] [Abstract][Full Text] [Related]
5. In vivo studies on non-viral transdifferentiation of liver cells towards pancreatic β cells.
Cim A; Sawyer GJ; Zhang X; Su H; Collins L; Jones P; Antoniou M; Reynes JP; Lipps HJ; Fabre JW
J Endocrinol; 2012 Sep; 214(3):277-88. PubMed ID: 22685335
[TBL] [Abstract][Full Text] [Related]
6. PDGF Facilitates Direct Lineage Reprogramming of Hepatocytes to Functional β-Like Cells Induced by Pdx1 and Ngn3.
Chang FP; Cho CH; Shen CR; Chien CY; Ting LW; Lee HS; Shen CN
Cell Transplant; 2016 Oct; 25(10):1893-1909. PubMed ID: 27076404
[TBL] [Abstract][Full Text] [Related]
7. Generation of insulin-producing cells from the mouse liver using β cell-related gene transfer including Mafa and Mafb.
Nagasaki H; Katsumata T; Oishi H; Tai PH; Sekiguchi Y; Koshida R; Jung Y; Kudo T; Takahashi S
PLoS One; 2014; 9(11):e113022. PubMed ID: 25397325
[TBL] [Abstract][Full Text] [Related]
8. Sequential introduction and dosage balance of defined transcription factors affect reprogramming efficiency from pancreatic duct cells into insulin-producing cells.
Miyashita K; Miyatsuka T; Matsuoka TA; Sasaki S; Takebe S; Yasuda T; Watada H; Kaneto H; Shimomura I
Biochem Biophys Res Commun; 2014 Feb; 444(4):514-9. PubMed ID: 24472553
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic Ducts.
Wang Y; Dorrell C; Naugler WE; Heskett M; Spellman P; Li B; Galivo F; Haft A; Wakefield L; Grompe M
Mol Ther; 2018 May; 26(5):1327-1342. PubMed ID: 29550076
[TBL] [Abstract][Full Text] [Related]
10. Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive β Cells Prior to Transplantation into Diabetic Recipients.
Zhu Y; Tonne JM; Liu Q; Schreiber CA; Zhou Z; Rakshit K; Matveyenko AV; Terzic A; Wigle D; Kudva YC; Ikeda Y
Stem Cell Reports; 2019 Aug; 13(2):307-321. PubMed ID: 31378674
[TBL] [Abstract][Full Text] [Related]
11. Establishing a Large-Animal Model for In Vivo Reprogramming of Bile Duct Cells into Insulin-Secreting Cells to Treat Diabetes.
Hill CM; Banga A; Abrahante JE; Yuan C; Mutch LA; Janecek J; O'Brien T; Graham ML; Dutton JR
Hum Gene Ther Clin Dev; 2017 Jun; 28(2):87-95. PubMed ID: 28363269
[TBL] [Abstract][Full Text] [Related]
12. PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration.
Zhu Y; Liu Q; Zhou Z; Ikeda Y
Stem Cell Res Ther; 2017 Nov; 8(1):240. PubMed ID: 29096722
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA.
Wang L; Huang Y; Guo Q; Fan X; Lu Y; Zhu S; Wang Y; Bo X; Chang X; Zhu M; Wang Z
Diabetes Res Clin Pract; 2014 Jun; 104(3):383-92. PubMed ID: 24794627
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of mice primary hepatocytes into insulin-producing cells by transfection with multicistronic vectors.
Luo H; Chen R; Yang R; Liu Y; Chen Y; Shu Y; Chen H
J Diabetes Res; 2014; 2014():716163. PubMed ID: 25006589
[TBL] [Abstract][Full Text] [Related]
15. Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach.
Fodor A; Harel C; Fodor L; Armoni M; Salmon P; Trono D; Karnieli E
Diabetologia; 2007 Jan; 50(1):121-30. PubMed ID: 17131142
[TBL] [Abstract][Full Text] [Related]
16. The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improves the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells.
Xu H; Tsang KS; Chan JC; Yuan P; Fan R; Kaneto H; Xu G
Cell Transplant; 2013; 22(1):147-58. PubMed ID: 22776709
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver.
Wang AY; Ehrhardt A; Xu H; Kay MA
Mol Ther; 2007 Feb; 15(2):255-63. PubMed ID: 17235302
[TBL] [Abstract][Full Text] [Related]
18. Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming.
Swales N; Martens GA; Bonné S; Heremans Y; Borup R; Van de Casteele M; Ling Z; Pipeleers D; Ravassard P; Nielsen F; Ferrer J; Heimberg H
PLoS One; 2012; 7(5):e37055. PubMed ID: 22606327
[TBL] [Abstract][Full Text] [Related]
19. Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy.
Ren B; O'Brien BA; Byrne MR; Ch'ng E; Gatt PN; Swan MA; Nassif NT; Wei MQ; Gijsbers R; Debyser Z; Simpson AM
J Gene Med; 2013 Jan; 15(1):28-41. PubMed ID: 23293075
[TBL] [Abstract][Full Text] [Related]
20. Generation of functional insulin-producing cells from mouse embryonic stem cells through 804G cell-derived extracellular matrix and protein transduction of transcription factors.
Kaitsuka T; Noguchi H; Shiraki N; Kubo T; Wei FY; Hakim F; Kume S; Tomizawa K
Stem Cells Transl Med; 2014 Jan; 3(1):114-27. PubMed ID: 24292793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
